Kezar Life Sciences, Inc. - KZR

Ownership (Schedule 13D / 13G) · latest 50 filings · Back to all files
Visible: 0
Filed Form Reporting person Percent Shares SEC
May 28, 2026 SCHEDULE 13G/A Baselake Partners, LP 0.0% 0 View
May 28, 2026 SCHEDULE 13G/A Baselake Management, LLC 0.0% 0 View
May 28, 2026 SCHEDULE 13G/A David Paolella 0.0% 0 View
May 13, 2026 SCHEDULE 13D/A — 5.0% — View
May 12, 2026 SCHEDULE 13G/A Baselake Partners, LP 0.0% 0 View
May 12, 2026 SCHEDULE 13G/A Baselake Management, LLC 0.0% 0 View
May 12, 2026 SCHEDULE 13G/A David Paolella 0.0% 391,862 View
May 12, 2026 SCHEDULE 13G/A BML Investment Partners, L.P. 0.0% 0 View
Apr 06, 2026 SCHEDULE 13G Baselake Partners, LP 5.3% 391,862 View
Apr 06, 2026 SCHEDULE 13G Baselake Management, LLC 5.3% 391,862 View
Apr 06, 2026 SCHEDULE 13G David Paolella 5.3% 391,862 View
Apr 01, 2026 SCHEDULE 13D/A — 100.0% — View
Feb 13, 2026 SCHEDULE 13G/A Stonepine Capital Management, LLC 2.1% 156,179 View
Feb 13, 2026 SCHEDULE 13G/A Stonepine Capital, L.P. 2.1% 156,179 View
Feb 13, 2026 SCHEDULE 13G/A Stonepine GP, LLC 2.1% 156,179 View
Feb 13, 2026 SCHEDULE 13G/A Jon M. Plexico 2.1% 156,179 View
Feb 09, 2026 SCHEDULE 13G/A BML Investment Partners, L.P. 9.8% 720,787 View
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G. Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F). Amendments (/A) can repeat the same holder over time, so rows should not be summed. Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.